Mapping the emergence and development of translational cancer research

European Journal of Cancer

Volumn 42, Issue 18, 2006, Pages 3140-3148

  Cambrosio, Alberto ^a   Keating, Peter ^b   Mercier, Simon ^b   Lewison, Grant ^c   Mogoutov, Andrei ^d  

^a MCGILL UNIVERSITY   (Canada)

^b UNIVERSITÉ DU QUÉBEC À MONTRÉAL   (Canada)

^c Evaluametrics   (United Kingdom)

^d Aguidel   (France)

Author keywords

Bibliometric analysis; Clinical cancer research; Intercitation networks; Neoplasms; Translational research

Indexed keywords

ARTICLE; BIOMEDICINE; CANCER RESEARCH; COMPUTER PROGRAM; LABORATORY; MEDICAL RESEARCH; PRIORITY JOURNAL; TIME SERIES ANALYSIS;

BIOMEDICAL RESEARCH; DATABASES, FACTUAL; HUMANS; INFORMATION SERVICES; INTERPROFESSIONAL RELATIONS; MEDICAL ONCOLOGY; PERIODICALS; SEMANTICS;

EID: 33845293453     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejca.2006.07.020     Document Type: Article

References (20)

1. Coleman C.N., and Harris J.R. Current scientific issues related to clinical radiation oncology. Radiation Res 150 (1998) 125-133
2. Chabner B.A., Boral A.L., and Multani P. Translational research: Walking the bridge between idea and cure. Seventeenth Bruce F. Cain Memorial Award Lecture. Cancer Res 58 (1998) 4211-4216
3. Pollak M. Peptide growth factors and breast cancer treatment: Recent translational research. Recent Results Cancer Res 140 (1996) 43-49
4. Ahrens E.H. The crisis in clinical research: Overcoming institutional obstacles (1992), Oxford University Press, New York
5. Schechter A.N., Perlman R.L., and Rettig R.A. Editors' introduction: Why is revitalizing clinical research so important, yet so difficult?. Perspect Biol Med 47 (2004) 476-486
6. Nathan D.G. Careers in translational clinical research. Historical perspectives, future challenges. JAMA 287 (2002) 2424-2427
7. Dill K.A. Strengthening Biomedicine's Roots. Nature 400 (1999) 309-330
8. Schechter A.N. Medicine and biology are more than biomedicine. Nature 401 (1999) 424
9. Keating P., and Cambrosio A. Biomedical platforms. Realigning the normal and the pathological in late-twentieth-century medicine (2003), MIT Press, Cambridge, MA
10. Keating P., and Cambrosio A. Does biomedicine entail the successful reduction of pathology to biology?. Perspect Biol Med 47 (2004) 357-371
11. Gaudillière J.P. Inventer la biomédecine: la France, l'Amérique et la production des savoirs du vivant (1945-1965) (2002), La Découverte, Paris
12. In: de Chadarevian S., and Kamminga H. (Eds). Molecularizing biology and medicine. New practices and alliances, 1910s-1970s (1998), Harwood Academic Publishers, Amsterdam
13. Ugolini D., and Mela G.S. Oncological research overview in the European Union. A 5-year survey. Eur J Cancer 39 (2003) 1888-1894
14. Grossi F., Belvedere O., and Rosso R. Geography of clinical cancer research publications from 1995 to 1999. Eur J Cancer 39 (2003) 106-111
15. Lewison G. The definition and calibration of biomedical subfields. Scientometrics 46 (1999) 529-537
16. Lewison G., and Paraje G. The classification of biomedical journals by research level. Scientometrics 60 (2004) 145-157
17. Cambrosio A., Keating P., and Mogoutov A. Mapping collaborative work and innovation in biomedicine: A computer-assisted analysis of antibody reagent workshops. Soc Stud Sci 34 (2004) 325-364
18. Bourret P., Mogoutov A., Julian-Reynier C., and Cambrosio A. A new clinical collective for French cancer genetics: A heterogeneous mapping analysis. Sci Technol Human Values 31 (2006) 431-464
19. Widdows D. Geometry and Meaning (2003), The University of Chicago Press, Chicago
20. Krueger G. The Formation of the American Society of Clinical Oncology and the Development of a Medical Specialty, 1964-1973. Perspect Biol Med 47 (2004) 535-537